1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6FA35DF434FAEDC0C85257B960062B31D
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/consumer-marketing-research-innovation-program-effectiveness-obstacles-DTC-hurdles-and-lessons-learned?opendocument
18
19opendocument
203.85.10.62
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Market Research, Analytics and Forecasting Process Excellence and Productivity Management

Consumer Marketing Research Innovation: Program Effectiveness & Obstacles, DTC Hurdles and Lessons Learned

ID: 5257


Features:

10 Info Graphics

10 Data Graphics

100+ Metrics

2 Narratives


Pages/Slides: 28


Published: Pre-2014


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Consumer Marketing Research Innovation: Program Effectiveness & Obstacles, DTC Hurdles and Lessons Learned"


STUDY OVERVIEW

Not only are technological advances reshaping the landscape for communicating with consumers but also they are creating the opportunity for consumer marketing research innovation. Still, even in this environment of innovation there are many obstacles that can blunt the effectiveness of marketing research groups.

Best Practices, LLC conducted this cross-industry benchmarking study to illustrate how market research leaders view their effectiveness and what they believe are the primary obstacles they are facing. The study also examines the leading factors for not using DTC and presents participants' lessons learned for using new technologies and innovation in market research.

This study includes data on three segments: pharmaceutical companies, non-pharmaceutical companies and the Total Benchmark Class.

KEY TOPICS

  • Self-Rating of Market Research Groups
  • Factors Affecting Market Research Groups
  • Direct-to-Consumer Marketing
  • Best Practices, Pitfalls & Lessons Learned

SAMPLE KEY METRICS
  • Rate overall Market Research Effectiveness in your organization (Total Benchmark Class)
  • Rate overall Market Research Effectiveness in your organization (Pharma and Non-Pharma)
  • Factors that are impeding Market Research Effectiveness in your organization (Total Benchmark Class)
  • Factors that are impeding Market Research Effectiveness in your organization (Pharma)
  • Factors that are impeding Market Research Effectiveness in your organization (Non-Pharma)
  • Factors for not employing a DTC campaign for a new product
  • Factors for not employing a DTC campaign for a new product (Pharma)
  • Factors for not employing a DTC campaign for a new product (Non-Pharma)
  • What are your top lessons learned for using new technologies and innovative approaches for conducting consumer marketing research
  • What are your top lessons learned for using new technologies and innovative approaches for educating and communicating with consumers

SAMPLE KEY FINDINGS
  • Pharma Segment Rates Its Market Research Higher than Non-pharma Segment’s Self-Assessment of Its Market Research: The Pharma Segment perceives its Market Research operations to be more effective than the Non-pharma Segment’s assessment of its Market Research operations. While 22% of the pharma participants believe their groups are “highly effective,” only 15 % of the non-pharma companies see themselves as highly effective. Likewise, 61% of the pharma companies rated themselves as somewhat effective while 55% of the Non-pharma Segment rated their Market Research groups as somewhat effective.

STUDY METHODOLOGY


Fifty-nine benchmark survey respondents from 58 companies participated in this study. In addition, research analysts conducted executive interviews with eight selected respondents to collect qualitative data and insights.

Industries Profiled:
Pharmaceutical; Health Care; Market Research; Marketing; Service; Transportation; Insurance; Advertising; Biotech; Biopharmaceutical; Clinical Research; Laboratories; Utilities; Consulting; Manufacturing; Financial Services; Telecommunications; Education; Real Estate; Electronics; Computer Hardware; Computer Software; Communications; Medical Device; Professional Services; Consumer Products


Companies Profiled:
Grifols; HIT Global; Sample Answers; Lifestyle Marketing; Veeda Clinical Research; Metropolitan; Midwest Employers Casualty Company; Catalpha; Sanofi; SMUD; ic axon; SCL Systems Consulting; Coleman; The SoNo Group; DDI; IBS; Merck Serono; uatae; National Housing Trust; MTS; Daiichi Sankyo; Sekisanchi ; Landmark Group; Emirates Post; Ferring Pharmaceuticals; 20/20 Research; CDW; Quadra; GE Healthcare; vetoquinol; synergesic; Independence Blue Cross; ARIAD; gemalto; Teva Neuroscience; Klick Health; EMD Serono; EPR; Merck; Bright Horizons; Teva Pharmaceutical Industries Ltd; R2Business Solutions; Janssen; brunner; Novo Nordisk; Zillner; Johnson & Johnson; HFS Research; Biogen Idec; Medtronic; UCB Pharma; American Dental Association; Maxcom; China HR Insight; Convergys; Unilever; MidAmerican Energy Company; Emirates Group


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.